Clinical and serological findings of giant-cell arteritis

被引:0
作者
Vaith, P. [1 ]
Warnatz, K. [1 ]
机构
[1] Univ Freiburg Klinikum, Med Klin, Abt Rheumatol & Klin Immunol, D-79106 Freiburg, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2009年 / 68卷 / 02期
关键词
Giant cell arteritis; Polymyalgia rheumatica; Vasculitis; C-reactive protein; C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; POSITRON-EMISSION-TOMOGRAPHY; COMPLICATION AORTIC-ANEURYSM; POLYMYALGIA-RHEUMATICA; TEMPORAL ARTERITIS; CLASSIFICATION; INVOLVEMENT; PREVALENCE; DISSECTION;
D O I
10.1007/s00393-008-0377-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Giant cell arteritis (GCA) frequently appears as cranial arteritis (eg. temporal arteritis) with headache, pain on chewing and visual disturbances. In addition, extracranial manifestations are often observed leading to aneurysmatic dilatations and dissections of the aorta as well as stenoses of large thoracic, abdominal or limb arteries. The vascular signs are accompanied by general disease symptoms, e. g. malaise, elevated temperatures, weight loss and depression. Polymyalgia rheumatica (PMR) is the most frequent rheumatic manifestation of GCA but also occurs independently from GCA. The structural correlate for the PMR symptoms is first and foremost extra-articular inflammation (tenosynovitis, bursitis) of large joints and the vertebral column (interspinal bursitis). In addition, vasculitis of large arteries in PMR must be considered particularly in the presence of high inflammatory activity. While specific laboratory markers for GCA and PMR are lacking elevated values for the erythrocyte sedimentation rate and C-reactive protein are present in almost all patients at disease onset. Besides the clinical evaluation, the serological acute phase reaction represents the main parameter for the course during therapy of this relatively frequent disease in elderly people.
引用
收藏
页码:124 / +
页数:7
相关论文
共 50 条
  • [31] Treatment of giant-cell arteritis, a literature review
    Watelet, Benedicte
    Samson, Maxime
    de Boysson, Hubert
    Bienvenu, Boris
    MODERN RHEUMATOLOGY, 2017, 27 (05) : 747 - 754
  • [32] Giant Cell Arteritis and Mortality
    Crow, R. Wade
    Katz, Bradley J.
    Warner, Judith E. A.
    Alder, Stephen C.
    Zhang, Kang
    Schulman, Susan
    Digre, Kathleen B.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2009, 64 (03): : 365 - 369
  • [33] THE QUEST FOR THE IDEAL THERAPY FOR GIANT-CELL ARTERITIS
    GONZALEZGAY, MA
    REVUE DU RHUMATISME, 1995, 62 (7-8): : 539 - 539
  • [34] Ultrasound in giant cell arteritis
    Aschwanden, M.
    Imfeld, S.
    Schaeberle, W.
    Staub, D.
    Daikeler, T.
    GEFASSCHIRURGIE, 2019, 24 (01): : 68 - 74
  • [35] ANGIOGRAPHIC FINDINGS IN GIANT-CELL ARTERITIS OF THE ARM ARTERIES
    MICKLEY, V
    FRIEDRICH, JM
    SUNDERPLASSMANN, L
    FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1992, 157 (06): : 579 - 583
  • [36] EPIDEMIOLOGY OF BIOPSY-PROVEN GIANT-CELL ARTERITIS (GCA)
    NORDBORG, E
    BENGTSSON, BA
    JOURNAL OF INTERNAL MEDICINE, 1990, 227 (04) : 233 - 236
  • [37] Case Report: Granulomatous Liver Disease and Giant-Cell Arteritis
    Michael A. Heneghan
    Ken M. Feeley
    Nicola Defaoite
    Malcolm P.G. Little
    Thomas A. O'Gorman
    Digestive Diseases and Sciences, 1998, 43 : 2164 - 2167
  • [38] Giant-cell arteritis
    Hall, Jennifer K.
    CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (06) : 454 - 460
  • [39] GIANT-CELL ARTERITIS
    HAAS, C
    POIRIER, JM
    LOWENSTEIN, W
    DURAND, H
    SEMAINE DES HOPITAUX, 1995, 71 (21-22): : 641 - 647
  • [40] Clinical Diagnosis and Management of Large Vessel Vasculitis: Giant Cell Arteritis
    Chatterjee, Soumya
    Flamm, Scott D.
    Tan, Carmela D.
    Rodriguez, E. Rene
    CURRENT CARDIOLOGY REPORTS, 2014, 16 (07)